Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS stock drops after Blue Shield of California drops the pharmacy for Amazon and Cost Plus
06:07pm, Thursday, 17'th Aug 2023
Steve Valiquette, Barclays analyst, joins 'Closing Bell Overtime' to talk Blue Shield California's announcement it is dropping CVS and switching to Amazon and Mark Cuban's Cost Plus Drugs.
CVS Retains Blue Plan's Specialty Pharmacy Business And That's Where The Money And Costs Are
05:21pm, Thursday, 17'th Aug 2023
CVS Caremark will provide Blue Shield of California members "specialty pharmacy services for members with complex conditions, including education and high-touch patient support.”
CVS Health says loss of Blue Shield business has no significant impact on longer-term outlook, stock down 8%
04:11pm, Thursday, 17'th Aug 2023
CVS Health Corp. CVS, -8.13% expects a major health insurer's decision to reduce its reliance on CVS Caremark pharmacy benefit manager services will have “an immaterial impact on our longer-term out
CVS Stock Hits 2-Year Low After Blue Shield Snub
03:09pm, Thursday, 17'th Aug 2023
CVS Health Corp (NYSE:CVS) is down 8.7% to trade at $66.43 at last check, after news that Blue Shield of California is dropping the retailer's pharmacy services in favor of Mark Cuban's Cost Plus Dru
Why CVS Health Stock Crashed 11 Percent Today
11:43am, Thursday, 17'th Aug 2023
Is Blue Shield of California dumping CVS Health in favor of Amazon.com to manage its pharmacy benefits? Yes and no.
CVS stock plunges after Blue Shield of California drops company's PBM to save on drug costs
11:30am, Thursday, 17'th Aug 2023
Blue Shield's announcement hints at the potential for health insurers to abandon the traditional PBM system.
CVS Stock Alert: Blue Shield of California Ditches CVS for Mark Cuban
10:29am, Thursday, 17'th Aug 2023
CVS Health (NYSE: CVS ) stock is taking a beating on Thursday after health insurance company Blue Shield revealed plans to switch away from its pharmacies. Blue Shield, which is a non-profit health in
Here's Why You Should Retain CVS Health (CVS) Stock for Now
10:17am, Thursday, 17'th Aug 2023
Investors are optimistic about CVS Health's (CVS) continued growth across the insured and self-insured medical, pharmacy, dental and behavioral health products and services.
Major Insurer Blue Shield Of California Drops CVS For Amazon, Cuban's Cost Plus Drugs In Cost-Cutting Move
10:06am, Thursday, 17'th Aug 2023
Cost Plus Drug Company, Abarca and Amazon Pharmacy will replace a majority of the services currently provided by CVS Caremark.
CVS Health stock slides as Blue Shield of California drops Caremark
09:11am, Thursday, 17'th Aug 2023
CVS Health Corp (NYSE:CVS) shares fell more than 7% in pre-market trading on Thursday after The Wall Street Journal reported that Blue Shield of California will no longer be using CVS Health's Carema
CVS Stock Falls. Blue Shield of California Is Dropping Caremark.
08:06am, Thursday, 17'th Aug 2023
Blue Shield of California is dropping CVS's Caremark, its current pharmacy-benefit manager, and replacing it with a selection of other companies including drug delivery from Amazon.
Blue Shield of California to drop CVS Caremark as pharmacy benefit manager - WSJ
07:33am, Thursday, 17'th Aug 2023
Non-profit health insurer Blue Shield of California plans to drop CVS Health's Caremark as its pharmacy-benefit manager, the Wall Street Journal reported on Thursday.
CVS stock drops after WSJ report on Blue Shield of California dropping pharma benefit services with its Caremark unit
07:16am, Thursday, 17'th Aug 2023
CVS Health Corp. CVS, -0.83% stock was down 5.3% in premarket trades on Thursday after The Wall Street Journal reported that Blue Shield of California is dropping CVS Health's Caremark as its pharmacy
Michael Burry's Bold Moves and Big Short
06:05pm, Wednesday, 16'th Aug 2023
Michael Burry (Trades, Portfolio), the famed investor who gained prominence for predicting the 2008 financial crisis, is making waves once more with his Q2 2023 investment positions.
Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation
12:51pm, Wednesday, 16'th Aug 2023
This is an update to an earlier article I published on Walgreens and CVS back in April 2023. That article evaluated Walgreens and CVS using Peter Lynch's approach for dividend stocks, and the results
